Literature DB >> 22800551

The pathology of melanoma.

Clay J Cockerell1.   

Abstract

Although melanoma represents only 10% of all skin cancer diagnoses, it accounts for at least 65% of all skin cancer-related deaths. The number of new cutaneous melanoma cases projected during 2010 was 68,000-a 23% increase from the 2004 prediction of 55,100 cases. In 2015, the lifetime risk of developing melanoma is estimated to increase to 1 in 50. As the incidence of melanoma continues to rise, now more than ever, clinicians and histopathologists must have familiarity with the various clinical and pathologic features of cutaneous melanoma.
Copyright © 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22800551     DOI: 10.1016/j.det.2012.04.007

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  9 in total

1.  Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma.

Authors:  M Corazzari; F Rapino; F Ciccosanti; P Giglio; M Antonioli; B Conti; G M Fimia; P E Lovat; M Piacentini
Journal:  Cell Death Differ       Date:  2014-11-07       Impact factor: 15.828

2.  Fisetin inhibits human melanoma cell growth through direct binding to p70S6K and mTOR: findings from 3-D melanoma skin equivalents and computational modeling.

Authors:  Deeba N Syed; Jean-Christopher Chamcheu; Mohammad Imran Khan; Mario Sechi; Rahul K Lall; Vaqar M Adhami; Hasan Mukhtar
Journal:  Biochem Pharmacol       Date:  2014-03-24       Impact factor: 5.858

3.  eIF6 as a Promising Diagnostic and Prognostic Biomarker for Poorer Survival of Cutaneous Melanoma.

Authors:  Fangyingnan Zhang; Saquib Waheed; Ubaldo Armato; Jun Wu; Chao Zhang; Zhibin Li
Journal:  Front Oncol       Date:  2022-05-30       Impact factor: 5.738

4.  Local anesthetic thoracoscopy for the diagnosis of metastatic pleural melanoma originated from oral malignant melanoma: case report and comments.

Authors:  Bingjun Yang; Qingzhao Li; Hui Zhao; Huibin Liu; Tao Tang; Chunyang Jiang
Journal:  World J Surg Oncol       Date:  2015-12-01       Impact factor: 2.754

5.  Prognostic significance of LKB1 promoter methylation in cutaneous malignant melanoma.

Authors:  Weiming Zhang; Xiao Li; Guoxin Song; Dan Luo
Journal:  Oncol Lett       Date:  2017-06-20       Impact factor: 2.967

6.  Patterns of Change During the Dermoscopic Follow-Up of Melanocytic Lesions in High Risk Patients.

Authors:  Loredana Ungureanu; Alina Letcă; Simona Corina Șenilă; Ana Sorina Dănescu; Rodica Cosgarea
Journal:  Clujul Med       Date:  2015-01-28

7.  Oral malignant melanoma: A case report with review of literature.

Authors:  T Manigandan; G Vikram Sagar; A Amudhan; V T Hemalatha; N Aravinda Babu
Journal:  Contemp Clin Dent       Date:  2014-07

8.  Pronounced peptide selectivity for melanoma through tryptophan end-tagging.

Authors:  Dinh Thuy Duong; Shalini Singh; Mojtaba Bagheri; Navin Kumar Verma; Artur Schmidtchen; Martin Malmsten
Journal:  Sci Rep       Date:  2016-04-27       Impact factor: 4.379

9.  Design and biological evaluation of novel BF-30 analogs for the treatment of malignant melanoma.

Authors:  Jia Qi; Weiwei Wang; Wenying Lu; Wei Chen; Hui Sun; Anquan Shang
Journal:  J Cancer       Date:  2020-10-18       Impact factor: 4.207

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.